These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1637132)

  • 21. Prioritizing problem features in Korean patients with senile dementia for implementation of monitoring technologies.
    Tack GR; Choi MH; Lee SJ; Yang JW; Kim JH; Choi JS; Jun JH; Lee JW; Park JY; Moon SW; Chung SC
    Psychiatry Res; 2011 May; 187(3):418-23. PubMed ID: 20659771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Very mild senile dementia of the Alzheimer type. I. Clinical assessment.
    Rubin EH; Morris JC; Grant EA; Vendegna T
    Arch Neurol; 1989 Apr; 46(4):379-82. PubMed ID: 2650663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Danish Alzheimer intervention study: rationale, study design and baseline characteristics of the cohort.
    Waldemar G; Waldorff FB; Buss DV; Eckermann A; Keiding N; Rishøj S; Siersma V; Sørensen J; Sørensen LV; Vogel A
    Neuroepidemiology; 2011; 36(1):52-61. PubMed ID: 21196773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive features in mild senile dementia of the Alzheimer type.
    Berg L; Danziger WL; Storandt M; Coben LA; Gado M; Hughes CP; Knesevich JW; Botwinick J
    Neurology; 1984 May; 34(5):563-9. PubMed ID: 6538648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Methodology of a long-term study of senile dementia].
    Wertheimer J; Brull J
    Schweiz Arch Neurol Neurochir Psychiatr; 1977; 120(2):309-22. PubMed ID: 905795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very mild senile dementia of the Alzheimer type. II. Psychometric test performance.
    Storandt M; Hill RD
    Arch Neurol; 1989 Apr; 46(4):383-6. PubMed ID: 2705897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-recognition in senile dementia.
    Biringer F; Anderson JR; Strubel D
    Exp Aging Res; 1988; 14(4):177-80. PubMed ID: 3251763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mild senile dementia of Alzheimer type: research diagnostic criteria, recruitment, and description of a study population.
    Berg L; Hughes CP; Coben LA; Danziger WL; Martin RL; Knesevich J
    J Neurol Neurosurg Psychiatry; 1982 Nov; 45(11):962-8. PubMed ID: 7175540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychometric differentiation of mild senile dementia of the Alzheimer type.
    Storandt M; Botwinick J; Danziger WL; Berg L; Hughes CP
    Arch Neurol; 1984 May; 41(5):497-9. PubMed ID: 6721715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a review.
    Thompson PA; Wright DE; Counsell CE; Zajicek J
    Int Psychogeriatr; 2012 May; 24(5):689-97. PubMed ID: 21910950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal, behavioral study of senile dementia of the Alzheimer type.
    Botwinick J; Storandt M; Berg L
    Arch Neurol; 1986 Nov; 43(11):1124-7. PubMed ID: 3778244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial remediation of speaker and listener behaviors in people with severe dementia.
    Henry LM; Horne PJ
    J Appl Behav Anal; 2000; 33(4):631-4. PubMed ID: 11214039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Need for and challenges facing functional communication as outcome parameter in AD clinical trials.
    Haberstroh J; Wollstadt P; Knebel M; Oswald F; Schröder J; Pantel J
    Alzheimer Dis Assoc Disord; 2013; 27(4):293-301. PubMed ID: 23751370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of naltrexone on senile dementia of the Alzheimer type.
    Hyman BT; Eslinger PJ; Damasio AR
    J Neurol Neurosurg Psychiatry; 1985 Nov; 48(11):1169-71. PubMed ID: 3001233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addressing the challenges of transforming laboratory advances into Alzheimer's Disease treatments.
    Karlawish JH; Clark CM
    Neurobiol Aging; 2002; 23(6):1043-9. PubMed ID: 12470801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term survival, place of death, and death certification in clinically diagnosed pre-senile dementia in northern England. Follow-up after 8-12 years.
    Kay DW; Forster DP; Newens AJ
    Br J Psychiatry; 2000 Aug; 177():156-62. PubMed ID: 11026956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aphasia, family history, and the longitudinal course of senile dementia of the Alzheimer type.
    Knesevich JW; Toro FR; Morris JC; LaBarge E
    Psychiatry Res; 1985 Mar; 14(3):255-63. PubMed ID: 2408291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Senile dementia of the Alzheimer type. Subject attrition and testability in research.
    Botwinick J; Storandt M; Berg L; Boland S
    Arch Neurol; 1988 May; 45(5):493-6. PubMed ID: 3258741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug therapy for senile dementia of the Alzheimer type].
    Hariguchi S
    Nihon Ronen Igakkai Zasshi; 1988 Jul; 25(4):385-9. PubMed ID: 3074197
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of global assessment measures in dementia drug trials.
    Rockwood K
    J Clin Epidemiol; 1994 Jan; 47(1):101-3. PubMed ID: 8283190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.